Literature DB >> 7796395

Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas.

H Tahara1, T Nakanishi, M Kitamoto, R Nakashio, J W Shay, E Tahara, G Kajiyama, T Ide.   

Abstract

Telomerase activity was examined in 105 frozen samples from human normal liver tissues, chronic liver disease, and hepatocellular carcinoma (HCC). Telomerase activity was positive in 28 of 33 HCC tissues regardless of tumor stage or size. Telomerase was expressed in 15 of 18 differentiated HCC nodules smaller than 3 cm. HCC tissues from all eight hepatitis B virus-positive patients were telomerase positive, while telomerase activity was not detected in normal liver tissues (0 of 4). Weak telomerase activity was only detected in 1 of 22 nontumor liver tissues from HCC patients. Interestingly, in 19 of 38 hepatitis tissues and 6 of 8 cirrhotic liver tissues from apparently cancer-free patients, very weak telomerase activity was detected. These results indicate that the expression of telomerase may play a crucial role in hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7796395

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  55 in total

1.  Telomere, telomerase and digestive cancer.

Authors:  Javed Yakoob; Guo-Ling Hu; Xue-Gong Fan; Zheng Zhang
Journal:  World J Gastroenterol       Date:  1999-08       Impact factor: 5.742

2.  A rapid, useful and quantitative method to measure telomerase activity by hybridization protection assay connected with a telomeric repeat amplification protocol.

Authors:  M Hirose; J Abe-Hashimoto; K Ogura; H Tahara; T Ide; T Yoshimura
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

Review 3.  How long should telomeres be?

Authors:  A Aviv; C B Harley
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

4.  p53-expressing conditionally replicative adenovirus CNHK500-p53 against hepatocellular carcinoma in vitro.

Authors:  Hong-Chuan Zhao; Qi Zhang; Yang Yang; Min-Qiang Lu; Hua Li; Chi Xu; Gui-Hua Chen
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

5.  Telomerase activity and hepatic functions of rat embryonic liver progenitor cell in nanoscaffold-coated model bioreactor.

Authors:  Shibashish Giri; Karen Nieber; Ali Acikgöz; Sanja Pavlica; Mario Keller; Augustinus Bader
Journal:  Mol Cell Biochem       Date:  2009-10-09       Impact factor: 3.396

6.  Difference in hTERT gene expressions between HbsAg-positive and HbsAg-negative hepatocellular carcinoma.

Authors:  Yueqing Guo; Xu Zhou; Enyu Liu; Xingrui Li; Jinwen Liu; Zhifang Yang; Jilin Yi
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

7.  Regulation of telomerase activity in immortal cell lines.

Authors:  S E Holt; W E Wright; J W Shay
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

8.  Cell cycle-dependent modulation of telomerase activity in tumor cells.

Authors:  X Zhu; R Kumar; M Mandal; N Sharma; H W Sharma; U Dhingra; J A Sokoloski; R Hsiao; R Narayanan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

Review 9.  Telomerase activity, cell proliferation, and cancer.

Authors:  C W Greider
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

10.  DNAzyme-based probes for telomerase detection in early-stage cancer diagnosis.

Authors:  Hui Wang; Michael J Donovan; Ling Meng; Zilong Zhao; Youngmi Kim; Mao Ye; Weihong Tan
Journal:  Chemistry       Date:  2013-02-20       Impact factor: 5.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.